StageWise Strategies (STWI) EBITDA (2023 - 2026)
StageWise Strategies recorded quarterly EBITDA of $18671.0 in Q1 2026, up 552.3% quarter-over-quarter from -$4128.0 in Q4 2025, and up 524.24% year-over-year from $2991.0 in Q1 2025.
StageWise Strategies' EBITDA history runs 4 years deep, the most recent figure standing at $18671.0 for Q1 2026.
- In Q1 2026, EBITDA rose 524.24% year-over-year to $18671.0; the TTM figure through Mar 2026 stood at -$55069.0 (down 318.21% YoY), while the FY2025 annual figure was -$40126.0, down 131.62% from the prior year.
- EBITDA came in at $18671.0 for Q1 2026 at StageWise Strategies, up from -$4128.0 in the prior quarter.
- In the past five years, EBITDA ranged from a high of $33886.0 in Q4 2024 to a low of -$43116.0 in Q2 2025.
- A 4-year average of -$4290.8 and a median of -$4264.5 in 2025 frame the typical range for EBITDA.
- Across the five-year window, EBITDA sank 1790.82% in 2025 and jumped 524.24% in 2026, its largest moves.
- StageWise Strategies' EBITDA stood at -$10731.0 in 2023, then surged by 415.78% to $33886.0 in 2024, then tumbled by 112.18% to -$4128.0 in 2025, then jumped by 552.3% to $18671.0 in 2026.
- According to Business Quant data, EBITDA over the past three periods registered $18671.0, -$4128.0, and -$26496.0 for Q1 2026, Q4 2025, and Q3 2025 respectively.
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 18,671.00 |
| Dec 31, 2025 | -4,128.00 |
| Sep 30, 2025 | -26,496.00 |
| Jun 30, 2025 | -43,116.00 |
| Mar 31, 2025 | -4,401.00 |
| Dec 31, 2024 | 33,886.00 |
| Sep 30, 2024 | -6,798.00 |
| Jun 30, 2024 | 2,550.00 |
| Mar 31, 2024 | -2,345.00 |
| Dec 31, 2023 | -10,731.00 |